Skip to content
DataLookout
Menu

Dementia clinical trials

Get alerts when Dementia trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-22

What changed in the last 30 days

134 trials changed in the last 30 days: 5 stopped, 55 with notable changes, 74 with minor changes only.

  1. Stopped: CarES · Penn State Emergency Medicine CarES: Care-partner Evaluation and Sourcing in the Emergency Department Withdrawn before enrolling Milton S. Hershey Medical CenterNot applicable NCT07461168
  2. Notable: SHR 3201 Injection in Healthy Participants Recruitment opened Beijing Suncadia Pharmaceuticals Co., LtdPhase 1 NCT07889349
  3. Notable: STAND · Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Dementia Results posted: Nov 20, 2026 Emory UniversityPhase 4 NCT04522739
  4. Minor: GERAS-US · Health Care Use and Costs · Early Stage Alzheimer's Disease (AD) Trial completed Eli Lilly and CompanyNot specified NCT02951598
  5. Minor: MAINSTREAM · Multimodal Approach for Clinical Diagnosis and Treatment of Primary Progressive Aphasia, MAINSTREAM ID:3430931 Trial status changed: Unknown → Completed IRCCS Centro San Giovanni di Dio FatebenefratelliNot applicable NCT05730023
  6. Minor: DemReg · German Dementia Registry Trial sites expanded: 24 → 29 locations RWTH Aachen UniversityNot specified NCT07433010
  7. Stopped: VNS · Vagus Nerve Stimulation to Enhance Memory in Aging Withdrawn before enrolling Stanford UniversityNot applicable NCT07214194
  8. Notable: Benefits of Personalised Music in Dementia - a Feasibility Study Primary and study completion pushed from Apr 30, 2026 to Nov 30, 2027 Music for my MindNot specified NCT04132362
  9. Notable: Self-Control Module of a Positive Mental Health Promotion Programme for Adult Informal Caregivers · Dementia: Protocol for a Randomised Controlled Trial Enrollment reopened University Rovira i VirgiliNot applicable NCT07577440
  10. Notable: Personalized Optimal Gamma Auditory Frequency Stimulation Intervention on Cognitive Function Enhancement Recruitment opened Chang Gung Memorial HospitalNot applicable NCT07690865
  11. Notable: Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin Eligibility criteria changed National Institute on Aging (NIA)Phase 2 NCT07721467
  12. Notable: BHPRO-IMP · Implementing Brain Health PRO Across Diverse Settings: A Multi-Site Implementation Study Eligibility criteria changed Centre de Recherche de l'Institut Universitaire de Geriatrie de MontrealNot applicable NCT07935629
  13. Minor: PAS-MCI · Acoustic Stimulation During Sleep: Effects on Memory and p-tau217 in MCI Primary completion pushed from Sep 2027 to Dec 2027 Institut de Recerca Biomèdica de Lleida-Fundació Dr. Pifarré (IRBLleida)Not applicable NCT07529015
  14. Minor: DIAN-TU · Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments · a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation Trial sites reduced: 36 → 31 locations Washington University School of MedicinePhase 2/3 NCT05269394
  15. Minor: DUET-AD · Dual Study Assessing Safety and Efficacy of Buntanetap · Early AD Final enrollment: 861 participants (planned 760) Annovis Bio Inc.Phase 3 NCT06709014
  16. Minor: LIPUS-Brain · Early Alzheimer's Disease Study completion pushed from Jul 31, 2026 to Mar 31, 2027 Sound Wave Innovation CO., LTD.Phase 3 NCT05983575
  17. Notable: CORDIAL · Attenuation of Postprandial Inflammatory Processes in Alzheimer's Disease Patients by Consumption of Pomace Oil Primary completion pushed from May 30, 2026 to Dec 30, 2026 Spanish National Research CouncilNot applicable NCT06245616
  18. Notable: SVAT · Differencens in VO2-max, Perfusion of the Heart and Brain and Cognitive Performance Between · Type 2 Diabetes and Healthy Age Matched Controls Primary completion pushed from Jan 2027 to Dec 2, 2027 University Hospital Bispebjerg and FrederiksbergNot specified NCT06628297
  19. Notable: LY4560736 in Healthy Participants and · Alzheimer's Disease (AD) Recruitment opened Eli Lilly and CompanyPhase 1 NCT07843459
  20. Notable: TOBY ATLAS · Urine Volatile Organic Compounds for Disease Detection Eligibility criteria changed Toby, Inc.Not specified NCT07933042
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-11-19 NCT07947953 A Prospective, Randomized, Placebo-Controlled Double Blind, 18 Month Study Evaluating the… Koser, Robert B., MD PA new
2026-11-17 NCT07943702 Correlation Between Visual Reading and DOlab Software Quantitative Analysis of DaT-SPECT… Dorian Technologies S.r.l. new
2026-11-12 NCT07930364 Wearable HRV Biofeedback for Stress in Dementia Caregivers Instituto de Investigación Marqués de Valdecilla new
2026-11-12 NCT07933042 A Study of Urine Volatile Organic Compounds for Disease Detection Toby, Inc. new
2026-11-09 NCT07926438 40 Hz Audio-Visual Stimulation Therapy for AD The First Affiliated Hospital of Xiamen University new
2026-11-05 NCT07918638 Prospective Research on Identification of Dementia in Early Stages (P.R.I.D.E) Don Mottola Medical Center new
2026-11-03 NCT07912710 China HEalthy Aging and Dementia Study (HEAD) Fudan University new
2026-10-30 NCT07907042 Effects of Doll Therapy on Apathy and Activities of Daily Living Initiation Deficits in… Xinyu ZHANG new
2026-10-30 NCT07905872 Feasibility of Community Occupational Therapy for Dementia (COT-D) University of Vic - Central University of Catalonia new
2026-10-29 NCT07905352 A Phase 2 Clinical Study of Simenafil Hydrochloride Tablets in the Treatment of… Vigonvita Life Sciences new Phase 2

Active trials by phase

Early Phase 1
21
Phase 1
76
Phase 1/2
50
Phase 2
138
Phase 2/3
18
Phase 3
70
Phase 4
32
Not charted: 1,112 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Get alerts when Dementia trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free

Narrower conditions

Active trials